Advertisement
Home Tags Health Costs

Tag: Health Costs

Medicare could save billions of dollars if secondary fractures could be prevented with improved osteoporosis screening

Medicare Spends More Than $6 Billion on Secondary Fractures

A fracture should trigger clinical attention to reduce the risk for future fractures, authors say
In 2019

Average Annual Premium for Workers Increased in 2019

Average annual premium increased to $7,188 for single coverage, $20,576 for family coverage
House Speaker Nancy Pelosi has revealed a plan to lower the cost of medications for people on Medicare and those with private insurance.

House Speaker Unveils Plan to Lower Drug Costs

Plan would allow Medicare to negotiate prices for high-cost drugs
Americans with rheumatic disease struggle to access affordable specialty care

Patients With Rheumatic Disease Often Have Trouble Accessing Care

Access issues include getting specialty appointments and affording treatment
Financial integration between physicians and hospitals raises patient spending but does not impact care quality

Spending Up With Treatment in Hospital-Owned Practices

Difference in spending seems to be due to greater service utilization; no difference seen in care quality
Probiotics could reduce the health care and economic burden of flu-like respiratory tract infections

Model Estimates Effect of Probiotics on Costs for Flu-Like Illnesses

Cost savings could include reductions in respiratory tract infections, antibiotic prescriptions, sick days
The cost per colonoscopy

Costs of Reusable Colonoscopes Vary Based on Center Volume

Cost per colonoscopy ranges from $188.64 at high-volume centers to $501.16 at low-volume centers
From 2006 to 2016

Prices Spike for Drugs Used to Treat Multiple Sclerosis

2006-2016 Medicare claims show 10.2-fold, 7.2-fold hikes in pharmaceutical, out-of-pocket spending
Women with diagnosed diabetes are more likely than men to not take their medications as prescribed

Women With Diabetes More Likely Than Men to Not Take Meds as Prescribed

Younger adults more likely to not take meds as prescribed and to ask for lower-cost medication
The economic burden of disease progression is considerable among multiple myeloma patients receiving drug therapy across all lines of therapy

Cost Burden of Disease Progression High in Multiple Myeloma

For patients receiving drug therapy, economic burden substantial across lines of therapy